Filing Details
- Accession Number:
- 0001127602-14-010746
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-07 17:23:59
- Reporting Period:
- 2014-03-06
- Filing Date:
- 2014-03-07
- Accepted Time:
- 2014-03-07 17:23:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1447121 | Francois Carbonnel De | One Amgen Center Drive Thousand Oaks CA 91320-1799 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-06 | 5,000 | $58.43 | 20,364 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-03-06 | 5,000 | $50.44 | 25,364 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-06 | 6,021 | $126.19 | 19,343 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-03-06 | 1,000 | $126.69 | 18,343 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nqso (Right to Buy) | Disposition | 2014-03-06 | 5,000 | $0.00 | 5,000 | $58.43 |
| Common Stock | Nqso (Right to Buy) | Disposition | 2014-03-06 | 5,000 | $0.00 | 5,000 | $50.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-04-26 | 2020-04-26 | No | 4 | M | Direct |
| 0 | 2010-04-28 | 2016-04-28 | No | 4 | M | Direct |
Footnotes
- All shares were sold at $126.69.
- These shares include 95 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
Billionaire Hedge Funds
